vialroom

#retatrutide 2025-07-29

Tuesday11 messages3 participantstimes are UTC
Highlights from this day
  • dark_for_ten_days — Medutest came back 96.8 on one lot and 98.6 on the next from the same SGN, both fine 06:04
  • dark_for_ten_days — the half life supports weekly dosing and thats what ive done from the start, happy to be corrected 06:06
  • osaka_assay — the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial 06:07
  • osaka_assay — TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule stepping in 2.4 increments instead of doubling is the only thing i would change if… 06:37
  • osaka_assay — reconstituted the 40 vial to 4mg/ml specifically so i could take 2 without measuring crumbs, i have it written down somewhere 06:39
DF

nobody should read my log as a plan, im recording what i did and thats all it is, n of 1 obviously

buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely

the half life supports weekly dosing and thats what ive done from the start, happy to be corrected

🔥12📈11💀2
OA

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial

📈11
OA

TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule
stepping in 2.4 increments instead of doubling is the only thing i would change if i started again

chromatogram-overlay.png
1240 × 720 · 895 KB · not retained in the public archive

*that should say weekly

reconstituted the 40 vial to 4mg/ml specifically so i could take 2 without measuring crumbs, i have it written down somewhere

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.

the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me